Physician profile
Karima Chen
NPI 1891416715
$988.43
in general payments reported to CMS, 2019-2025
11 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $245 · 2023: $466 · 2024: $108 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $597.39 | 2022-2025 | |
| Exact Sciences Corporation | $81.71 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $67.46 | 2022-2023 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $51.66 | 2023-2024 | Descovy |
| Collegium Pharmaceutical, INC. | $44.65 | 2025 | Jornay Pm |
| Pfizer INC. | $32.95 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.01 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.46 | 2023 | Rexulti |
| Lilly USA, LLC | $22.35 | 2023 | Trulicity, Mounjaro |
| Xeris Pharmaceuticals, INC. | $21.39 | 2023 | Gvoke Hypopen |
| Kowa Pharmaceuticals America, INC. | $14.40 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karima Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.